Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Stoke Therapeutics
3107
Stoke Therapeutics
Technology
Biotechnology
Health Care
Medical
Therapeutics
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment of severe genetic diseases.
Suggest edits
Type
B2b
Founded
2017
Raised
$130M
Follow us
Companies in the same industry
AntriaBio
Abeona Therapeutics
Codiak Biosciences
Puma Biotechnology
Lysosomal Therapeutics
Allinaire Therapeutics
CerSci Therapeutics
Anvajo
LifeMine Therapeutics
Genomics plc
Alexa global traffic share
Overview
Funding
2
Add info
Latest funding
$90,000,000
Venture capital (Series B) - 2018
RTW Investments
$40,000,000
Venture capital (Series A) - 2018
Apple Tree Partners
Team Size
10+
Employees
I work here
Location
United States
Headquarters
Explore United States
$90,000,000
Venture capital (Series B)
FinSMEs
,
PE HUB
Stoke Therapeutics Raises $90M in Series B Financing
Funding
Health
FinSMEs
Stoke Therapeutics Raises $40M in Series A Financing
Science
Health
Funding
